zoledronic acid has been researched along with Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blue, ME; Boskey, AL; Doty, SB; Lukashova, L; Shapiro, JR | 1 |
| Bahi-Buisson, N; Brailly-Tabard, S; Célestin, E; Charles, P; Durand, E; Fontaine, I; Lambert, AS; Linglart, A; Miladi, L; Rothenbuhler, A; Trabado, S; Wicart, P | 1 |
| Brezin, F; Dousset, B; Feillet, F; Hernandez, M; Lambert, L; Renard, E; Weryha, G; Wiedemann, A | 1 |
3 other study(ies) available for zoledronic acid and Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome
| Article | Year |
|---|---|
Zoledronic acid improves bone histomorphometry in a murine model of Rett syndrome.
Topics: Animals; Cancellous Bone; Cortical Bone; Diphosphonates; Disease Models, Animal; Imidazoles; Male; Methyl-CpG-Binding Protein 2; Mice; Mice, Inbred C57BL; Mice, Knockout; Rett Syndrome; X-Ray Microtomography; Zoledronic Acid | 2017 |
Lower incidence of fracture after IV bisphosphonates in girls with Rett syndrome and severe bone fragility.
Topics: Adolescent; Adult; Bone Density; Bone Density Conservation Agents; Calcium; Child; Creatinine; Diphosphonates; Female; Fractures, Bone; Humans; Imidazoles; Incidence; Pamidronate; Rett Syndrome; Young Adult; Zoledronic Acid | 2017 |
Annual Injection of Zoledronic Acid Improves Bone Status in Children with Cerebral Palsy and Rett Syndrome.
Topics: Adolescent; Bone and Bones; Bone Density; Bone Density Conservation Agents; Cerebral Palsy; Child; Fractures, Bone; Humans; Imidazoles; Osteoporosis; Rett Syndrome; Time Factors; Zoledronic Acid | 2019 |